JP2023078418A5 - - Google Patents

Download PDF

Info

Publication number
JP2023078418A5
JP2023078418A5 JP2023049452A JP2023049452A JP2023078418A5 JP 2023078418 A5 JP2023078418 A5 JP 2023078418A5 JP 2023049452 A JP2023049452 A JP 2023049452A JP 2023049452 A JP2023049452 A JP 2023049452A JP 2023078418 A5 JP2023078418 A5 JP 2023078418A5
Authority
JP
Japan
Prior art keywords
tautomer
trifluoromethyl
alkyl
compound
pyrazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023049452A
Other languages
English (en)
Japanese (ja)
Other versions
JP7698676B2 (ja
JP2023078418A (ja
Filing date
Publication date
Priority claimed from PCT/US2020/062020 external-priority patent/WO2021108408A1/en
Application filed filed Critical
Publication of JP2023078418A publication Critical patent/JP2023078418A/ja
Publication of JP2023078418A5 publication Critical patent/JP2023078418A5/ja
Application granted granted Critical
Publication of JP7698676B2 publication Critical patent/JP7698676B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023049452A 2019-11-25 2023-03-27 デルタ-5デサチュラーゼ阻害剤としての複素環式化合物及び使用方法 Active JP7698676B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962939821P 2019-11-25 2019-11-25
US62/939,821 2019-11-25
PCT/US2020/062020 WO2021108408A1 (en) 2019-11-25 2020-11-24 Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use
JP2022529556A JP7254246B2 (ja) 2019-11-25 2020-11-24 デルタ-5デサチュラーゼ阻害剤としての複素環式化合物及び使用方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022529556A Division JP7254246B2 (ja) 2019-11-25 2020-11-24 デルタ-5デサチュラーゼ阻害剤としての複素環式化合物及び使用方法

Publications (3)

Publication Number Publication Date
JP2023078418A JP2023078418A (ja) 2023-06-06
JP2023078418A5 true JP2023078418A5 (enExample) 2023-11-20
JP7698676B2 JP7698676B2 (ja) 2025-06-25

Family

ID=73855555

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022529556A Active JP7254246B2 (ja) 2019-11-25 2020-11-24 デルタ-5デサチュラーゼ阻害剤としての複素環式化合物及び使用方法
JP2023049452A Active JP7698676B2 (ja) 2019-11-25 2023-03-27 デルタ-5デサチュラーゼ阻害剤としての複素環式化合物及び使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022529556A Active JP7254246B2 (ja) 2019-11-25 2020-11-24 デルタ-5デサチュラーゼ阻害剤としての複素環式化合物及び使用方法

Country Status (21)

Country Link
US (3) US11512097B2 (enExample)
EP (1) EP4065223A1 (enExample)
JP (2) JP7254246B2 (enExample)
KR (2) KR20230154292A (enExample)
CN (2) CN114728167B (enExample)
AR (1) AR120556A1 (enExample)
AU (1) AU2020392087B2 (enExample)
BR (1) BR112022010054A2 (enExample)
CA (1) CA3162281A1 (enExample)
CL (2) CL2022001357A1 (enExample)
CO (1) CO2022008690A2 (enExample)
CR (1) CR20220308A (enExample)
IL (1) IL293191B2 (enExample)
JO (1) JOP20220125A1 (enExample)
MX (1) MX2022006281A (enExample)
PE (1) PE20231097A1 (enExample)
PH (1) PH12022551282A1 (enExample)
SA (1) SA522432710B1 (enExample)
TW (2) TWI815061B (enExample)
UY (1) UY38971A (enExample)
WO (1) WO2021108408A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11220510B2 (en) * 2018-04-09 2022-01-11 Incyte Corporation Pyrrole tricyclic compounds as A2A / A2B inhibitors
US11512097B2 (en) 2019-11-25 2022-11-29 Amgen Inc. Heterocyclic compounds as Delta-5 desaturase inhibitors and methods of use
CN115557903A (zh) * 2022-09-27 2023-01-03 山东潍坊润丰化工股份有限公司 一种特草定的制备方法
WO2024112763A1 (en) 2022-11-23 2024-05-30 Amgen Inc. Selection of patients for the treatment of fads1-mediated diseases or disorders using fads-1 inhibitors

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3130633A1 (de) 1981-08-01 1983-02-17 Basf Ag, 6700 Ludwigshafen 7-amino-azolo(1,5-a)pyrimidine und diese enthaltende fungizide
EP0242690B1 (en) 1986-04-07 1993-06-30 Kumiai Chemical Industry Co., Ltd. 5H-1,3,4-Thiadiazolo[3,2-a]pyrimidin-5-one derivatives and agricultural-horticultural fungicide composition containing the same
US6096753A (en) 1996-12-05 2000-08-01 Amgen Inc. Substituted pyrimidinone and pyridone compounds and methods of use
HUP0001140A3 (en) 1996-12-05 2002-05-28 Amgen Inc Thousand Oaks Substituted pyrimidinone and pyridone compounds and methods of use
ES2249302T3 (es) 1999-10-15 2006-04-01 Neurocrine Biosciences, Inc. Antagonistas del receptor de la hormona liberadora de gonadotropina y sus metodos de uso relacionados.
US6537998B1 (en) * 1999-10-15 2003-03-25 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
AU2003238157A1 (en) 2002-06-18 2003-12-31 Sankyo Company, Limited Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof
JP2004107228A (ja) 2002-09-17 2004-04-08 Nippon Nohyaku Co Ltd 双環性ピリミジノン誘導体及びこれを有効成分とする除草剤
AR049769A1 (es) 2004-01-22 2006-09-06 Novartis Ag Derivados de pirazolo(1,5-a)pirimidin 7-il-amina para utilizarse en el tratamiento de enfermedades dependientes de la quinasa de proteina
US20050222171A1 (en) 2004-01-22 2005-10-06 Guido Bold Organic compounds
BRPI0519288A2 (pt) 2004-12-24 2009-01-06 Astrazeneca Ab compostos heterocÍclicos como antagonistas de ccr2b
JP2008546843A (ja) 2005-06-27 2008-12-25 アムゲン インコーポレイティッド 抗炎症性アリールニトリル化合物
WO2007027012A1 (en) 2005-07-18 2007-03-08 Samsung Electronics Co., Ltd. Video coding method and apparatus for reducing mismatch between encoder and decoder
WO2007012602A1 (de) 2005-07-27 2007-02-01 Basf Aktiengesellschaft Fungizide 5-methyl-6-phenyl-triazolopyrimidinylamine
CN101228166A (zh) 2005-07-27 2008-07-23 巴斯福股份公司 杀真菌的6-苯基三唑并嘧啶基胺
ATE442370T1 (de) 2005-07-27 2009-09-15 Basf Se Fungizide 6-phenyl-pyrazolopyrimidin-7-ylamine
BRPI0616985B1 (pt) 2005-10-06 2021-10-26 Merck Sharp & Dohme Corp. Composto de pirazolo[1,5-a]pirimidina, e, uso de um composto
MX2009002995A (es) 2006-09-28 2009-04-01 Novartis Ag Derivados de pirazolo-[1,5-a]-pirimidina y su uso terapeutico.
CN101522676A (zh) 2006-10-05 2009-09-02 Cv医药有限公司 用作硬脂酰-CoA脱氢酶抑制剂的双环含氮杂环化合物
US8173661B2 (en) 2006-11-08 2012-05-08 The Rockefeller University Alpha-IIB-beta-3 inhibitors and uses thereof
WO2008089310A2 (en) 2007-01-18 2008-07-24 Lexicon Pharmaceuticals, Inc. Delta 5 desaturase inhibitors for the treatment of obesity
WO2008089307A2 (en) 2007-01-18 2008-07-24 Lexicon Pharmaceuticals, Inc. Delta 5 desaturase inhibitors for the treatment of pain, inflammation and cancer
EA015688B1 (ru) 2007-01-19 2011-10-31 Басф Се Фунгицидные смеси из анилидов 1-метилпиразол-4-илкарбоновой кислоты и азолопиримидиниламинов
WO2008092836A2 (en) 2007-01-30 2008-08-07 Basf Se Method for improving plant health
US8461077B2 (en) 2007-03-23 2013-06-11 Basf Se Combinations of active substances
US8642660B2 (en) 2007-12-21 2014-02-04 The University Of Rochester Method for altering the lifespan of eukaryotic organisms
CA2719362A1 (en) 2008-04-04 2009-10-08 Gilead Sciences, Inc. Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors
US8119647B2 (en) 2008-04-23 2012-02-21 Glenmark Pharmaceuticals S.A. Fused pyrimidineone compounds as TRPV3 modulators
US20100099561A1 (en) 2008-10-15 2010-04-22 E.I. Du Pont De Nemours And Company Heterobicyclic alkylthio-bridged isoxazolines
US20100190747A1 (en) 2009-01-27 2010-07-29 Hideo Suzuki Fused ring compound and use thereof
EP2845856A1 (en) 2009-06-29 2015-03-11 Incyte Corporation Pyrimidinones as PI3K inhibitors
WO2011114148A1 (en) 2010-03-17 2011-09-22 Astrazeneca Ab 4h- [1, 2, 4] triazolo [5, 1 -b] pyrimidin-7 -one derivatives as ccr2b receptor antagonists
JPWO2012011592A1 (ja) 2010-07-23 2013-09-09 武田薬品工業株式会社 複素環化合物およびその用途
WO2012125629A1 (en) 2011-03-14 2012-09-20 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
US8952012B2 (en) 2012-05-24 2015-02-10 Colorado State University Research Foundation Inhibition of delta-6 desaturase for the treatment of cardiometabolic disease
RU2015143517A (ru) 2013-03-13 2017-04-19 Дженентек, Инк. Пиразолсодержащие соединения и их применения
CA2922925A1 (en) 2013-09-05 2015-03-12 Genentech, Inc. Antiproliferative compounds
WO2015064714A1 (ja) 2013-10-31 2015-05-07 国立大学法人東京大学 オートタキシン阻害活性を有する1-置換イミダゾピリミジノン誘導体
WO2015135094A1 (en) 2014-03-13 2015-09-17 Genentech, Inc. Therapeutic compounds and uses thereof
AU2015251207B2 (en) 2014-04-23 2019-08-22 Mitsubishi Tanabe Pharma Corporation Novel bicyclic or tricyclic heterocyclic compound
WO2016183063A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Crystalline forms of a pi3k inhibitor
JP6791717B2 (ja) 2015-10-22 2020-11-25 田辺三菱製薬株式会社 医薬組成物
JP2017091808A (ja) 2015-11-10 2017-05-25 株式会社フジクラ 酸化物超電導線材の製造方法及び超電導コイルの製造方法
US11414385B2 (en) 2015-12-21 2022-08-16 The University Of Chicago Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan parasitic diseases
WO2018039972A1 (en) * 2016-08-31 2018-03-08 Agios Pharmaceuticals, Inc. Inhibitors of cellular metabolic processes
SG11201901747VA (en) 2016-08-31 2019-03-28 Agios Pharmaceuticals Inc Inhibitors of cellular metabolic processes
CN106749271B (zh) 2016-12-07 2019-04-05 青岛科技大学 一类[1,2,4]-三氮唑并[1,5-a]嘧啶酮类杂环化合物、其制备方法及其用途
US20200360381A1 (en) 2017-05-15 2020-11-19 Dana-Farber Cancer Institute, Inc. Compounds for treating dengue virus infection and other viral infections
WO2018229683A1 (en) 2017-06-15 2018-12-20 Novartis Ag 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases
WO2019055750A1 (en) 2017-09-15 2019-03-21 Aduro Biotech, Inc. PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF
US11512097B2 (en) 2019-11-25 2022-11-29 Amgen Inc. Heterocyclic compounds as Delta-5 desaturase inhibitors and methods of use

Similar Documents

Publication Publication Date Title
JP2024532733A (ja) 複素環式化合物及び使用方法
RU2424242C2 (ru) Азолопиримидины в качестве ингибиторов активности каннабиноидного рецептора 1
JP2024532735A (ja) 複素環式化合物及び使用方法
JP2025533831A (ja) Kras g12c変異タンパク質のテザー型複素環式阻害剤及びその使用
JP2025508702A (ja) キナゾリン化合物、及び変異krasタンパク質の阻害剤としてのその使用
JP2021528467A5 (enExample)
HRP20240935T1 (hr) Heterociklični i heteroaril spojevi za liječenje huntingtonove bolesti
JP2015511245A5 (enExample)
JP2024517693A (ja) 2-アミノベンゾチアゾール化合物及びその使用方法
JP2017518326A5 (enExample)
US20210163417A1 (en) Isoquinolines as inhibitors of hpk1
JP2016537384A5 (enExample)
RU2019120986A (ru) Фармацевтическая комбинация, содержащая ингибитор alk и ингибитор shp2
WO2022093856A1 (en) Heterocyclic spiro compounds and methods of use
RU2017121278A (ru) Триазоло-пиразинильные производные, применимые в качестве растворимых активаторов гуанилатциклазы
HRP20120105T1 (hr) Aminoheterociklički spojevi
AU2018201557A1 (en) Heteroaryl pyridone and aza-pyridone compounds as inhibitors of Btk activity
RU2012136907A (ru) Модуляторы гамма-секретазы
JP2013523884A5 (enExample)
JP2017524734A5 (enExample)
JP2011500774A5 (enExample)
JP2003531210A5 (enExample)
JP2016504363A5 (enExample)
JP2005502683A5 (enExample)
JP2013518823A5 (enExample)